Literature DB >> 17261334

Behavioural and neurochemical features of olfactory bulbectomized rats resembling depression with comorbid anxiety.

Dayong Wang1, Yukihiro Noda, Hiroko Tsunekawa, Yuan Zhou, Masayuki Miyazaki, Koji Senzaki, Toshitaka Nabeshima.   

Abstract

In order to probe the nature and validity of olfactory bulbectomized (OB) rats as a model of depression, we reevaluated their behavioural and neurochemical deficits in relation to the symptoms and neurochemical abnormalities of depression using our protocols, which distinguish anhedonia-resembling behaviour in sexual behavioural test, the hippocampus (Hip)-dependent long-term memory and anxiety-resembling behaviour specially. Besides exploratory hyperactivity in response to a novel environmental stress resembling the psychomotor agitation, OB rats showed a decrease of libido, and a deficit of long-term explicit memory, resembling loss of interest and cognitive deficits in depressive patients, respectively. OB rats also exhibited the anxiety symptom-resembling behaviour in social interaction and plus-maze tests. In the OB rats, we found degenerated neurons in the piriform cortex, decreased protein expression of NMDA receptor subunit 1 (NR1), but not NR2A or NR2B, in the prefrontal cortex (PFC), Hip and amygdala (Amg), and decreased phosphorylation of cAMP-response element-binding protein (CREB) in the PFC and Hip, but not Amg. The behavioural and neurochemical abnormalities in OB rats, except for the performance in the plus-maze task and neuronal degeneration, were significantly attenuated by repeated treatment with desipramine (10 mg/kg), a typical antidepressant. The present study indicated that OB rats may be a model of depression with comorbid anxiety, characterized by agitation, sexual and cognitive dysfunction, neuronal degeneration, decreased protein expression of NR1, and decreased phosphorylation of CREB.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17261334     DOI: 10.1016/j.bbr.2007.01.003

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  29 in total

Review 1.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

Review 2.  Pathogenesis of depression: Insights from human and rodent studies.

Authors:  C Ménard; G E Hodes; S J Russo
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

3.  Age-related impairments in memory and in CREB and pCREB expression in hippocampus and amygdala following inhibitory avoidance training.

Authors:  Ken A Morris; Paul E Gold
Journal:  Mech Ageing Dev       Date:  2012-03-16       Impact factor: 5.432

4.  Deep brain stimulation in rats: different targets induce similar antidepressant-like effects but influence different circuits.

Authors:  Clement Hamani; Beatriz O Amorim; Anne L Wheeler; Mustansir Diwan; Klaus Driesslein; Luciene Covolan; Christopher R Butson; José N Nobrega
Journal:  Neurobiol Dis       Date:  2014-08-13       Impact factor: 5.996

5.  Correlation of depressive symptoms and olfactory dysfunction in patients on hemodialysis.

Authors:  E Grapsa; E Samouilidou; K Pandelias; C Pipili; N Papaioannou; T Mpakirzi; H Tzanatos
Journal:  Hippokratia       Date:  2010-07       Impact factor: 0.471

6.  Olfactory bulbectomy impairs the feeding response to 2-deoxy-D-glucose in rats.

Authors:  Bruce M King; Stefany D Primeaux; Mohammad L Zadeh; John E de Gruiter; Joshua D Plant; Adam V Ferguson; George A Bray
Journal:  Brain Res       Date:  2010-10-20       Impact factor: 3.252

7.  Glial A30P alpha-synuclein pathology segregates neurogenesis from anxiety-related behavior in conditional transgenic mice.

Authors:  Franz Marxreiter; Benjamin Ettle; Verena E L May; Hakan Esmer; Christina Patrick; Christine Lund Kragh; Jochen Klucken; Beate Winner; Olaf Riess; Jürgen Winkler; Eliezer Masliah; Silke Nuber
Journal:  Neurobiol Dis       Date:  2013-07-16       Impact factor: 5.996

8.  Effect of combination of ketanserin and escitalopram on behavioral anomalies after olfactory bulbectomy: prediction of quick onset of antidepressant action.

Authors:  Dilip K Pandey; Shvetank Bhatt; Ankur Jindal; Baldev Gautam
Journal:  Indian J Pharmacol       Date:  2014 Nov-Dec       Impact factor: 1.200

9.  Is subclinical anxiety an endophenotype for bipolar I patients? A study from a Costa Rican sample.

Authors:  Javier Contreras; Elizabeth Hare; Adriana Pacheco; Michael Escamilla; Henriette Raventos
Journal:  J Affect Disord       Date:  2009-09-04       Impact factor: 4.839

10.  Telomerase deficiency affects normal brain functions in mice.

Authors:  Jaehoon Lee; Yong Sang Jo; Young Hoon Sung; In Koo Hwang; Hyuk Kim; Song-Yi Kim; Sun Shin Yi; June-Seek Choi; Woong Sun; Je Kyung Seong; Han-Woong Lee
Journal:  Neurochem Res       Date:  2009-08-15       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.